Skip to Main Content

Paper Details

Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance.
Open Forum Infectious Diseases
2
2022
Author NameAffiliation
Ellen H NagamiBrigham and Women's Hospital
Paul E SaxBrigham and Women's Hospital
Paul E SaxHarvard Medical School
  • 1 - 3

Datasets

Release 1.2